First look: new Drug's safety tested in healthy volunteers
NCT ID NCT07221084
Summary
This completed early-stage study aimed to understand how the body processes a new drug called atumelnant and to check its safety in healthy people. It involved 21 healthy Japanese and Caucasian adults who received either the drug or a placebo. The main goals were to measure drug levels in the blood and monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Crinetics Study Site
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.